Vanderbilt-Developed Obesity Treatments Will Be Advanced Through Collaboration With Soleno Therapeutics
February 26, 2021
February 26, 2021
NASHVILLE, Tennessee, Feb. 26 (TNSRes) -- Vanderbilt University issued the following news:
A new partnership between Vanderbilt University's Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes.
Leading the collaboration are WCNDD director Craig Lindsley, who holds the William K. Warren, Jr. Chair in Medicine, and Jerod Denton, . . .
A new partnership between Vanderbilt University's Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes.
Leading the collaboration are WCNDD director Craig Lindsley, who holds the William K. Warren, Jr. Chair in Medicine, and Jerod Denton, . . .